Lindsay Hyde
MONROAbout Lindsay Hyde
Independent director since 2017 (age 43), Hyde serves on MNRO’s Audit and Nominating & Corporate Responsibility Committees. She is an Entrepreneur in Residence at Moderne Ventures and a Senior Lecturer in Residence (Entrepreneurial Management) at Harvard Business School, with expertise in service delivery, marketing, risk management, HR, and community engagement. The Board has determined she is independent under Nasdaq rules; all directors attended at least 75% of meetings in FY2025 except one director (Auerbach), implying Hyde met the attendance threshold.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Baroo | Founder and CEO | Not disclosed | Service delivery and entrepreneurial execution |
| Strong Women, Strong Girls | Founder and Executive Director | Not disclosed | Community engagement and culture building |
| World Economic Forum | Global Shaper | Not disclosed | Global network participation |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Moderne Ventures | Entrepreneur in Residence | Current | VC focus: tech across real estate, mortgage, finance, insurance, hospitality, home services |
| Harvard Business School | Senior Lecturer in Residence (Entrepreneurial Management) | Current | Academic and entrepreneurial instruction |
| Harvard Alumni Association | Former Elected Director | Prior service | Alumni governance |
| Coca-Cola Scholars Alumni Foundation | Former Director | Prior service | Non-profit board experience |
Board Governance
- Committee memberships: Audit (member) and Nominating & Corporate Responsibility (member); Audit met 7 times in FY2025; Nominating met 2 times; all members—including Hyde—are independent, and the Audit Committee has two financial experts (McCluski and Woodhouse).
- Independence: Board is 100% independent; Chairman is independent (Robert E. Mellor), so no separate Lead Independent Director is designated.
- Attendance: Board held 6 meetings in FY2025; each director attended at least 75% except Auerbach (Hyde not flagged). Executive sessions of independent directors occur regularly.
- Policies: Anti-hedging and pledging policy for directors; executive compensation clawback policy; annual elections and declassified board; stock ownership guidelines in place.
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Board member annual cash retainer | $75,000 | Standard for non-employee directors |
| Audit Committee member fee | $15,000 | Member (not chair) |
| Nominating & Corporate Responsibility Committee member fee | $5,000 | Member (not chair) |
| Total cash fees earned (FY2025) | $95,000 | Matches Hyde’s director compensation table |
Performance Compensation
| Equity Award | Grant Date | Shares Granted | Grant Value | Vesting | Notes |
|---|---|---|---|---|---|
| Restricted Stock | Aug 13, 2024 | 4,937 | $129,991 (4,937 × $26.33) | Time-based over 3 years | Annual director grant; travel expenses reimbursed as applicable |
| Plan limit for non-employee directors | N/A | N/A | N/A | N/A | Total annual fees plus award value capped at $500,000 under Amended Restated Plan |
Performance metrics: Director equity awards are time-based; no performance metrics apply to director compensation.
Other Directorships & Interlocks
- Current public company directorships: None disclosed for Hyde.
- External affiliations are primarily venture and academic/non-profit; no disclosed interlocks with MNRO competitors, suppliers, or customers.
Expertise & Qualifications
- Experience in service delivery, marketing, strategic development/execution, risk management, and HR; entrepreneurial leadership and community engagement/culture.
- Audit Committee membership signals baseline financial literacy; Audit Committee’s designated financial experts are McCluski and Woodhouse (not Hyde).
Equity Ownership
| Item | Amount | Details |
|---|---|---|
| Total beneficial ownership (common shares) | 22,422 | Includes restricted stock grants with voting rights |
| Restricted stock outstanding (as of Mar 29, 2025) | 8,244 | Director RSAs outstanding count |
| Ownership as % of shares outstanding | <1% | Company reports “represents less than 1% ownership” |
| Stock ownership guideline | ≥3× annual cash retainer; 4-year compliance window | All non-employee directors in compliance as of Mar 29, 2025 |
| Hedging/pledging | Prohibited by policy | Applies to directors |
Insider trades (Form 4):
| Filing Date | Transaction Date | Type | Security | Shares | Price | Post-Transaction Ownership | Source |
|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-12 | Award (A) | Restricted Stock Award | 8,306 | $0.00 | 30,728 | |
| 2024-08-15 | 2024-08-13 | Award (A) | Restricted Stock Award | 4,937 | $0.00 | 22,422 |
Governance Assessment
- Strengths:
- Independent director with dual committee roles (Audit; Nominating & Corporate Responsibility) and adequate attendance; Board 100% independent with independent Chair.
- Equity alignment through annual restricted stock grants; directors comply with ownership guidelines; anti-hedging/pledging and clawback policies in place.
- Shareholder support: Say-on-Pay received ~99% approval in 2024, indicating general investor confidence in compensation oversight.
- Watch items:
- Related-party exposure at the company level (AlixPartners/APS engagement with CEO arrangement totaling ~$6.65M including addendum) warrants robust oversight; Audit Committee reviews related-party transactions per charter—Hyde’s Audit membership places her within that oversight.
- Red flags:
- None disclosed specific to Hyde: 2017 appointment 8-K noted no Item 404(a) related-party transactions involving Hyde; no pledging allowed; attendance threshold met.